---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-059067"
form_type: "8-K"
ticker: "NEO"
cik: "0001077183"
company_name: "NEOGENOMICS INC"
filed_at: "2025-12-30T23:59:59+00:00"
generated_at: "2026-05-16T11:57:31.038349+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# NeoGenomics appoints Jack Kenny to board; Dr. Alison Hannah departs after 10 years

## Summary
- Dr. Alison Hannah resigns from NeoGenomics board effective Dec 31, 2025, after over 10 years of service.
- Jack Kenny appointed to board effective Jan 1, 2026; former CEO of Meridian Bioscience (taken private 2023).
- Mr. Kenny brings 30+ years of diagnostics and lab services experience; also serves on Orasure, DCN, Quantum-SI boards.
- Mr. Kenny's compensation is consistent with NeoGenomics' director compensation plan as disclosed in 2025 proxy.
- No related-party transactions involving Mr. Kenny requiring disclosure under Item 404(a).

## SEC filing metadata
- accession: 0001628280-25-059067
- form_type: 8-K
- ticker: NEO
- cik: 0001077183
- company_name: NEOGENOMICS INC
- filed_at: 2025-12-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1077183/000162828025059067/0001628280-25-059067-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1077183/000162828025059067/neo-20251223.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-059067
- JSON: https://secwatch.observer/filing/0001628280-25-059067.json
- Plain text: https://secwatch.observer/filing/0001628280-25-059067.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.